CN101744892A - 首乌丹参滴丸中丹酚酸b含量测定方法 - Google Patents
首乌丹参滴丸中丹酚酸b含量测定方法 Download PDFInfo
- Publication number
- CN101744892A CN101744892A CN200810153630A CN200810153630A CN101744892A CN 101744892 A CN101744892 A CN 101744892A CN 200810153630 A CN200810153630 A CN 200810153630A CN 200810153630 A CN200810153630 A CN 200810153630A CN 101744892 A CN101744892 A CN 101744892A
- Authority
- CN
- China
- Prior art keywords
- salviae miltiorrhizae
- polygoni multiflori
- radix salviae
- dripping pills
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 title claims abstract description 57
- 239000002253 acid Substances 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 50
- 238000003908 quality control method Methods 0.000 claims abstract description 18
- 238000012360 testing method Methods 0.000 claims description 86
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 62
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 claims description 43
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 claims description 43
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 claims description 43
- 239000013558 reference substance Substances 0.000 claims description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 18
- 238000003556 assay Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 10
- 235000019253 formic acid Nutrition 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000009849 vacuum degassing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007718 Stable Angina Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810153630A CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810153630A CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101744892A true CN101744892A (zh) | 2010-06-23 |
CN101744892B CN101744892B (zh) | 2012-09-05 |
Family
ID=42472907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810153630A Expired - Fee Related CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101744892B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129817A (zh) * | 2007-09-26 | 2008-02-27 | 王福春 | 一种治疗高血压的中药制剂及其制备方法 |
-
2008
- 2008-11-28 CN CN200810153630A patent/CN101744892B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129817A (zh) * | 2007-09-26 | 2008-02-27 | 王福春 | 一种治疗高血压的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101744892B (zh) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103728387B (zh) | 参芪降糖制剂hplc标准指纹图谱及其构建方法 | |
CN103048409B (zh) | 一种同时检测止咳宝片中四种有效成分含量的方法 | |
CN107356691A (zh) | 建曲指纹图谱的检测方法 | |
CN110780007B (zh) | 一种hplc法一测多评测定芒果止咳片6种成分含量的方法 | |
CN113325094A (zh) | 一种古代经典名方复方制剂蠲痹颗粒三种活性成分含量同时测定的方法 | |
CN103808835A (zh) | Hplc-dad法同时测定四物汤煎剂中10种化学成分含量的方法 | |
CN106483084B (zh) | 一种固相萃取-比色法测定西洋参中总皂甙的方法 | |
CN103969350A (zh) | 一种穿王消炎胶囊hplc指纹图谱的建立方法 | |
CN103822975B (zh) | 一种党参方的生脉制剂的检测方法 | |
CN104007198B (zh) | 一种灵芝皇制剂hplc标准指纹图谱及其构建方法和应用 | |
CN110243988A (zh) | 壮药白花九里明hplc指纹图谱的建立方法 | |
CN109932441A (zh) | 一种舒肝宁注射液hplc指纹图谱的建立方法 | |
CN103575821A (zh) | 一种糖敏灵制剂中14种化学成分的检测方法 | |
CN1907340B (zh) | 一种测定肾石通制剂中槲皮素含量的方法 | |
CN102759558A (zh) | 电位滴定法测定五味子提取物中总有机酸的含量 | |
CN110187022A (zh) | 一种参倍固肠胶囊中人参皂苷Re含量的测定方法 | |
CN103389353A (zh) | 一种用超高效液相色谱法测定养血清脑颗粒中酚酸类成分含量的方法 | |
CN101744892A (zh) | 首乌丹参滴丸中丹酚酸b含量测定方法 | |
CN102008541B (zh) | 无糖型复方扶芳藤制剂中3种主要活性成分的同时检测方法 | |
CN102000209A (zh) | 一种龙掌口含液的质量检测方法 | |
CN102048906A (zh) | 鸡骨草胶囊的含量测定方法 | |
CN101274036A (zh) | 苁黄补肾制剂质量标准的检测方法 | |
CN108414667A (zh) | 一种参桂益心颗粒质量标准的检测方法 | |
CN108195967A (zh) | 中药制剂中芍药苷和毛蕊异黄酮葡萄糖苷的含量测定方法 | |
CN109557233B (zh) | 一种白芍提取液中多指标成分含量的测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant before: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN TIANSHILI PHARMACEUTICAL CO., LTD. TO: TASLY PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 Termination date: 20211128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |